T. Rowe Price Associates’s Stoke Therapeutics STOK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $497K | Buy |
43,735
+4,637
| +12% | +$52.7K | ﹤0.01% | 2303 |
|
|
2025
Q1 | $261K | Buy |
39,098
+1,643
| +4% | +$11K | ﹤0.01% | 2526 |
|
|
2024
Q4 | $414K | Buy |
37,455
+2,215
| +6% | +$24.5K | ﹤0.01% | 2356 |
|
|
2024
Q3 | $434K | Buy |
35,240
+194
| +0.6% | +$2.39K | ﹤0.01% | 2319 |
|
|
2024
Q2 | $474K | Buy |
35,046
+3,615
| +12% | +$48.9K | ﹤0.01% | 2210 |
|
|
2024
Q1 | $425K | Buy |
31,431
+1,642
| +6% | +$22.2K | ﹤0.01% | 2274 |
|
|
2023
Q4 | $157K | Hold |
29,789
| – | – | ﹤0.01% | 2612 |
|
|
2023
Q3 | $118K | Sell |
29,789
-329,133
| -92% | -$1.3M | ﹤0.01% | 2624 |
|
|
2023
Q2 | $3.82M | Sell |
358,922
-18,879
| -5% | -$201K | ﹤0.01% | 1257 |
|
|
2023
Q1 | $3.15M | Sell |
377,801
-17,306
| -4% | -$144K | ﹤0.01% | 1310 |
|
|
2022
Q4 | $3.65M | Sell |
395,107
-17,236
| -4% | -$159K | ﹤0.01% | 1257 |
|
|
2022
Q3 | $5.3M | Sell |
412,343
-4,378
| -1% | -$56.2K | ﹤0.01% | 1190 |
|
|
2022
Q2 | $5.51M | Sell |
416,721
-7,142
| -2% | -$94.3K | ﹤0.01% | 1410 |
|
|
2022
Q1 | $8.92M | Sell |
423,863
-14,384
| -3% | -$303K | ﹤0.01% | 1380 |
|
|
2021
Q4 | $10.5M | Buy |
438,247
+100,665
| +30% | +$2.42M | ﹤0.01% | 1401 |
|
|
2021
Q3 | $8.59M | Sell |
337,582
-49,841
| -13% | -$1.27M | ﹤0.01% | 1438 |
|
|
2021
Q2 | $13M | Sell |
387,423
-235,769
| -38% | -$7.94M | ﹤0.01% | 1382 |
|
|
2021
Q1 | $24.2M | Sell |
623,192
-126,434
| -17% | -$4.91M | ﹤0.01% | 1228 |
|
|
2020
Q4 | $46.4M | Buy |
749,626
+379,533
| +103% | +$23.5M | ﹤0.01% | 984 |
|
|
2020
Q3 | $12.4M | Sell |
370,093
-21,265
| -5% | -$712K | ﹤0.01% | 1250 |
|
|
2020
Q2 | $9.33M | Sell |
391,358
-36,164
| -8% | -$862K | ﹤0.01% | 1308 |
|
|
2020
Q1 | $9.79M | Sell |
427,522
-60,991
| -12% | -$1.4M | ﹤0.01% | 1229 |
|
|
2019
Q4 | $13.8M | Buy |
488,513
+106,200
| +28% | +$3.01M | ﹤0.01% | 1258 |
|
|
2019
Q3 | $8.22M | Buy |
382,313
+5,413
| +1% | +$116K | ﹤0.01% | 1317 |
|
|
2019
Q2 | $11M | Buy |
+376,900
| New | +$11M | ﹤0.01% | 1295 |
|